AMANDA GRIMES to Receptors, Thrombopoietin
This is a "connection" page, showing publications AMANDA GRIMES has written about Receptors, Thrombopoietin.
Connection Strength
0.743
-
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment: The PINES Randomized Clinical Trial. JAMA. 2025 11 25; 334(20):1816-1826.
Score: 0.231
-
Real-World Use of Avatrombopag in Children and Adolescents With Immune Thrombocytopenia. Pediatr Blood Cancer. 2026 01; 73(1):e32143.
Score: 0.230
-
Avatrombopag for the treatment of children and adolescents with immune thrombocytopenia (AVA-PED-301): a multicentre, randomised, double-blind, placebo-controlled, phase 3b study. Lancet Haematol. 2025 Jul; 12(7):e494-e504.
Score: 0.223
-
The association between immature platelet count and clinical characteristics in pediatric immune thrombocytopenia. Res Pract Thromb Haemost. 2026 Mar; 10(3):103417.
Score: 0.059